MedPath

Study to evaluate the effect of continuous intake of test food on the decrease of focusing accommodation attributed to eye strain -Crossover study

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000044917
Lead Sponsor
IMEQRD Co., Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1. Those who are attending a hospital or receiving treatment of medicines or Chinese medicines due to disease. 2. Those who had LASIK surgery in past. 3. Those who are receiving nutrition therapy or physical therapy under doctor's supervision. 4. Those who have a current or past medical history of severe diseases or organic eye disease. 5. Those who have entropion or trichiasis 6. Those whose measured value of astigmatometry is more than 1.25 D. 7. Those who wear eyelash extensions. 8. Those who do not have sleep enough. 9. Those who are likely to onset allergic conjunctivitis (seasonal or year-round) during this trial. 10. Those who currently and regularly use OTC medicines or quasi drugs (including eye drops), food for specified health uses, foods with functional claims, dietary supplements, or supplements. 11. Those who take yogurt or lactic acid bacteria drinks daily for health (However, except those who can quit taking them during this trial after obtaining consent). 12. Those who have current or history of drug allergies or food allergies. 13. Those who drink a lot of alcohol (60g/day alcohol conversion). 14. Those who have habit of smoking. 15. Those who are likely to change lifestyle (meal, sleep, motional activity), such as long trip, working night shift, and not able to keep certain lifestyle. 16. Those who are pregnant or lactating, or willing to be pregnant during the trial. 17. Those who had been participating in another clinical trial within one month before obtaining consent to the trial, or planning to participate during another clinical trial. 18. Those who were determined by the principal investigator to be unsuitable for this clinical test.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath